1. Home
  2. RCKY vs FHTX Comparison

RCKY vs FHTX Comparison

Compare RCKY & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

HOLD

Current Price

$33.49

Market Cap

273.7M

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$3.84

Market Cap

323.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKY
FHTX
Founded
1932
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
323.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RCKY
FHTX
Price
$33.49
$3.84
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$40.00
$11.50
AVG Volume (30 Days)
68.7K
102.8K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
1.71%
N/A
EPS Growth
94.74
25.32
EPS
0.17
N/A
Revenue
$270,408,000.00
$30,909,000.00
Revenue This Year
$8.12
$8.89
Revenue Next Year
$4.90
$20.13
P/E Ratio
$195.12
N/A
Revenue Growth
N/A
36.75
52 Week Low
$20.28
$3.27
52 Week High
$48.70
$6.95

Technical Indicators

Market Signals
Indicator
RCKY
FHTX
Relative Strength Index (RSI) 32.98 29.09
Support Level $31.86 $3.65
Resistance Level $34.36 $5.82
Average True Range (ATR) 2.01 0.27
MACD -0.57 -0.09
Stochastic Oscillator 14.13 2.68

Price Performance

Historical Comparison
RCKY
FHTX

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: